These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31541986)

  • 1. Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients.
    Issar T; Arnold R; Kwai NCG; Walker S; Yan A; Borire AA; Poynten AM; Pussell BA; Endre ZH; Kiernan MC; Krishnan AV
    Clin Neurophysiol; 2019 Nov; 130(11):2088-2095. PubMed ID: 31541986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering sensory axonal dysfunction in asymptomatic type 2 diabetic neuropathy.
    Sung JY; Tani J; Chang TS; Lin CS
    PLoS One; 2017; 12(2):e0171223. PubMed ID: 28182728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of chronic kidney disease and associated factors in Chinese individuals with type 2 diabetes: Cross-sectional study.
    Guo K; Zhang L; Zhao F; Lu J; Pan P; Yu H; Bao Y; Chen H; Jia W
    J Diabetes Complications; 2016 Jul; 30(5):803-10. PubMed ID: 27068269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes.
    Sung JY; Park SB; Liu YT; Kwai N; Arnold R; Krishnan AV; Lin CS
    Diabetes; 2012 Jun; 61(6):1592-8. PubMed ID: 22522615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Serum Homocysteine Levels and Severity of Diabetic Kidney Disease in 489 Patients with Type 2 Diabetes Mellitus: A Single-Center Study.
    Wu J; Liu D; Yang L; Liu J
    Med Sci Monit; 2022 Jun; 28():e936323. PubMed ID: 35684937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensory and motor axonal excitability testing in early diabetic neuropathy.
    Kristensen AG; Gylfadottir S; Itani M; Kuwabara S; Krøigård T; Khan KS; Finnerup NB; Andersen H; Jensen TS; Sindrup S; Tankisi H
    Clin Neurophysiol; 2021 Jul; 132(7):1407-1415. PubMed ID: 34030050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
    Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
    J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular filtration Rate, urine Albumin/ creatinine ratio and current perception threshold in patients with diabetic kidney disease.
    Pi CX; Gui TJ; He QD; Yin F; Cai RJ; Wang Y; Xue QX; Tian XK; Wang T; Zhe XW
    Diabetes Res Clin Pract; 2022 Jul; 189():109934. PubMed ID: 35640744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular autonomic neuropathy in chronic kidney diseases.
    Thapa L; Karki P; Sharma SK; Bajaj BK
    JNMA J Nepal Med Assoc; 2010; 49(178):121-8. PubMed ID: 21485597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of patients with type 2 diabetes attending a multidisciplinary diabetes kidney disease clinic.
    Low S; Lim SC; Wang J; Yeoh LY; Liu YL; Lim EK; Shao YL; Chui W; Fun S; Chua CL; Subramaniam T; Sum CF
    J Diabetes; 2018 Jul; 10(7):572-580. PubMed ID: 29154443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of urine Raman spectra differences from patients with diabetes mellitus and renal pathologies.
    Kavuru V; Senger RS; Robertson JL; Choudhury D
    PeerJ; 2023; 11():e14879. PubMed ID: 36874959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes.
    Kwai NCG; Arnold R; Poynten AM; Howells J; Kiernan MC; Lin CS; Krishnan AV
    Clin Neurophysiol; 2016 Feb; 127(2):1700-1706. PubMed ID: 26725257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo.
    Kwai NC; Nigole W; Poynten AM; Brown C; Krishnan AV
    PLoS One; 2016; 11(4):e0153389. PubMed ID: 27078166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects.
    Eid SA; Hinder LM; Zhang H; Eksi R; Nair V; Eddy S; Eichinger F; Park M; Saha J; Berthier CC; Jagadish HV; Guan Y; Pennathur S; Hur J; Kretzler M; Feldman EL; Brosius FC
    FASEB J; 2021 May; 35(5):e21467. PubMed ID: 33788970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of risk models for major adverse chronic renal outcomes among patients with type 2 diabetes mellitus using insurance claims: a retrospective observational study.
    Wysham CH; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Duh MS; Young JB
    Curr Med Res Opin; 2020 Feb; 36(2):219-227. PubMed ID: 31625766
    [No Abstract]   [Full Text] [Related]  

  • 17. Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy.
    Liu H; Tan S; Ma Z; Gao Q; Yang W
    J Diabetes Investig; 2024 Jan; 15(1):106-112. PubMed ID: 37794740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary Post-Translationally Modified Fetuin-A (uPTM-FetA) in Chronic Kidney Disease Patients with and without Diabetic Kidney Disease.
    Musolino M; Greco M; D'Agostino M; Tripodi L; Misiti R; Dragone F; Cianfrone P; Zicarelli M; Foti DP; Andreucci M; Bolignano D; Coppolino G
    Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541089
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study.
    Sasso FC; Pafundi PC; Gelso A; Bono V; Costagliola C; Marfella R; Sardu C; Rinaldi L; Galiero R; Acierno C; Caturano A; de Sio C; De Nicola L; Salvatore T; Nevola R; Adinolfi LE; Minutolo R;
    Nutr Metab Cardiovasc Dis; 2019 Sep; 29(9):923-930. PubMed ID: 31377186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T2DM/CKD genetic risk scores and the progression of diabetic kidney disease in T2DM subjects.
    Galuška D; Pácal L; Chalásová K; Divácká P; Řehořová J; Svojanovský J; Hubáček JA; Lánská V; Kaňková K
    Gene; 2024 Nov; 927():148724. PubMed ID: 38909968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.